On Friday, Indian share markets traded on a positive note most of the day and ended higher.
The BSE Sensex logged total gains of 1,417 points in the past six sessions - its longest winning streak since March. Investor sentiments increased amid hopes of an economic recovery and positive global sentiments.
At the closing bell on Friday, the BSE Sensex closed higher by 246 points to end the day at 39,298. Yes Bank and Maruti Suzuki were among the top gainers.
While the broader NSE Nifty ended up by 76 points to end at 11,662.
Among BSE sectoral indices, power stocks gained the most, followed by capital goods stocks and realty stocks.
From the media space, Zee Entertainment Enterprises Ltd (ZEEL) share price will be in focus today as the company reported a 6.73% year-on-year (YoY) rise in consolidated net profit at Rs 4.1 billion for the second quarter ended September 2019.
The growth here was driven by strong performance in domestic broadcast and digital businesses.
The company's total income rose 7.63% to Rs 21.9 billion during the quarter under review as against Rs 20.3 billion in the corresponding quarter last year.
ZEEL's total expenses in the quarter stood at Rs 15.1 billion as against Rs 13.8 billion in the year-ago period.
Total income during the April-September period rose 11.55% to Rs 43 billion as against Rs 38.5 billion a year ago.
Revenue from advertisement stood at Rs 12.2 billion during July-September, up 1.16% YoY.
Subscription revenue rose 18.96% YoY at Rs 7.2 billion during the quarter under review.
From the automobile sector, TVS Motors reported 20% jump in its standalone net profit for the September quarter (Q2FY20) at Rs 2.6 billion. The company had posted a profit of Rs 2.1 billion in the same quarter last year.
Revenues were down 13% at Rs 43.5 billion versus Rs 49.9 billion in the same quarter previous year.
Earnings before interest, tax, depreciation and amortization (EBITDA) was also down 10.8% at Rs 3.8 billion versus Rs 4.3 billion.
On a consolidated basis, the company has reported 15.1% rise in its net profit at Rs 2.6 billion for the quarter under review as compared to Rs 2.2 billion for the same quarter in the previous year.
However, total income of the company decreased by 9.2% at Rs 49.7 billion for Q2FY20 as compared to Rs 54.7 billion for the corresponding quarter previous year.
Speaking of the automobile sector, Research Analyst Apurva Sheth believes the BSE Auto index has entered the greed phase and will stay there for 32 months.
In the video below, he has identified 5 auto stocks that have entered the greed phase and present big money-making opportunities for traders as well as investors.
Tune in...
From the energy sector, BHEL share price will be in focus today. The stock of the company witnessed huge buying interest yesterday on reports suggesting that the government will likely to cut its stake in the company.
As per the news, the government may consider bringing down its stake in state-owned BHEL and National Mineral Development Corporation (NMDC).
The stake in BHEL may be pared in tranches to 26% from 63.17% now.
The government may also look to sell the state-run power player's non-manufacturing units to private players.
Four to five units of BHEL are reportedly marked for sale to private players this fiscal.
An inter-ministerial group is expected to meet soon to discuss the stake sale.
Earlier in October, the government cleared disinvestment in five PSUs, a move which is expected to cover nearly 60% of its disinvestment target for FY20.
The government has a divestment target of Rs 1.05 lakh crore for the current financial year. In both FY18 and FY19, the divestment proceeds exceeded the target of Rs 1 lakh crore and Rs 800 billion respectively.
How the above stake sale pans out remains to be seen. Meanwhile, we will keep you updated on all the developments from this space.
Moving on to the news from the pharma sector... Cipla has acquired a novel and patented anti-infective product, Elores, from Venus Remedies Ltd (VRL) for the Indian market.
The acquisition is aimed at further strengthening the firm's presence in branded Indian critical care space, and as a part of its agenda to contribute to the fight against anti-microbial resistance (AMR).
Elores is indicated for the treatment of life-threatening infections caused by gram-negative bacteria.
The product was launched in India across select tertiary care hospitals in the country in 2013 after approval from the Drug Controller General of India.
The company had recently acquired Zemdri, and with the acquisition of Elores, Cipla has added to its offering of new generation antibiotics.
China's economy expanded at its slowest rate in nearly three decades in the third quarter, hit by cooling domestic demand and a protracted US trade war.
According to the National Bureau of Statistics (NBS), gross domestic product (GDP) rose just 6% year-on-year, marking a further loss of momentum for the economy from the second quarter's 6.2% growth.
On Friday, Asian stocks stumbled on back of the above news, reversing gains made on the UK and European Union striking a long-awaited Brexit deal.
Earlier this month, US President Donald Trump said the two sides had reached agreement on the first phase of a deal and suspended a tariff hike, but officials warn much work still needed to be done.
Stay tuned for more updates from this space!
To know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Key Q2FY20 Results, BHEL Stake Sale, and Top Cues in Focus Today". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!